Drug Profile
Research programme: liver disease therapeutics - Affibody
Alternative Names: ABY-047; ABY-057Latest Information Update: 28 Jun 2021
Price :
$50
*
At a glance
- Originator Affibody
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Liver disorders